CID 3012101
Bdbm9114
Structural Information
- Molecular Formula
- C36H40ClF3N6O7
- SMILES
- CC1=NN=C(O1)C[C@H](C[C@@H](CN2CCN(C[C@H]2C(=O)NCC(F)(F)F)CC3=CC=C(O3)C4=CC=C(C=C4)Cl)O)C(=O)N[C@@H]5[C@@H](COC6=CC=CC=C56)O
- InChI
- InChI=1S/C36H40ClF3N6O7/c1-21-43-44-32(52-21)15-23(34(49)42-33-27-4-2-3-5-31(27)51-19-29(33)48)14-25(47)16-46-13-12-45(18-28(46)35(50)41-20-36(38,39)40)17-26-10-11-30(53-26)22-6-8-24(37)9-7-22/h2-11,23,25,28-29,33,47-48H,12-20H2,1H3,(H,41,50)(H,42,49)/t23-,25-,28-,29+,33-/m0/s1
- InChIKey
- HATHUICDJFFBJK-TZGIZZSYSA-N
- Compound name
- (2S)-4-[[5-(4-chlorophenyl)furan-2-yl]methyl]-1-[(2S,4S)-2-hydroxy-5-[[(3S,4S)-3-hydroxy-3,4-dihydro-2H-chromen-4-yl]amino]-4-[(5-methyl-1,3,4-oxadiazol-2-yl)methyl]-5-oxopentyl]-N-(2,2,2-trifluoroethyl)piperazine-2-carboxamide
- Related CIDs
2D Structure
Profile
Predicted Collision Cross Section
Adduct | m/z | Predicted CCS (Ų) |
---|---|---|
[M+H]+ | 761.26718 | 266.7 |
[M+Na]+ | 783.24912 | 266.3 |
[M-H]- | 759.25262 | 273.8 |
[M+NH4]+ | 778.29372 | 255.8 |
[M+K]+ | 799.22306 | 264.6 |
[M+H-H2O]+ | 743.25716 | 253.6 |
[M+HCOO]- | 805.25810 | 262.4 |
[M+CH3COO]- | 819.27375 | 285.6 |
[M+Na-2H]- | 781.23457 | 259.7 |
[M]+ | 760.25935 | 272.1 |
[M]- | 760.26045 | 272.1 |
Literature stripe
Patent stripe
No patent data available for this compound.